RE:Delta COVID-19 variant challengesQ2 and Q3 will see pretty much same level of testing and perhaps more as travel related testing increases in July. IMO. After that I expect a decrease in testing as population is fully vaccinated after end of Q3 into Q4.
Resilience19 wrote: Fox News (a rather far right fringe news source) reports that Delta (Indian) COVID-19 variant doubles risk of hospitalization compared to Alpha strain (https://www.foxnews.com/health/delta-covid-19-variant-doubles-risk-hospitalization-compared-alpha-strain-scottish-study) has become the dominant strain in the UK about a month ago, prompting Boris Johnson (Trump's alter ego) to delay easing of COVID-19 lockdown measures (https://www.foxnews.com/health/uk-extends-covid-19-restrictions-delta-variant).
Meanwhile the Delta variant has been spreading rapidly and is now present in 74 countries (https://newsconcerns.com/delta-variant-of-covid-spreading-rapidly-and-detected-in-74-countries-coronavirus/) and is about to become the dominant strain in the US (https://www.cbsnews.com/news/covid-19-delta-variant-gottlieb-face-the-nation/), highlighting the continued need to get the second vaccine shots, alongside continued testing (https://www.sciencemediacentre.org/expert-reaction-to-latest-update-from-phe-on-the-delta-variant/).
In short, although the epidemiological situation has been improving, this side of the pond, we're not yet out of the woods and need to remain proactive in addressing the root cause of the virus' dissemination (barrier measures, testing and immunization).
So, as Marshall has alluded to, we'll likely not see short-term reduction in testing.